Delivery Order SPE2DB20D9329-SPE2DB22FD4NZ
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,557,954,905 units of Naloxone hydrochloride 4 mg nasal spray. The contract has a ceiling value of $5,266.28 and an ultimate completion date of August 2, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,084.80 contract is for the delivery of 4,567,311,856 units of Naloxone HCl 4 mg Nasal Spray, a critical opioid overdose reversal medication, with a period of performance through February 20, 2025. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,393.26 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,558,189,631 units of Naloxone HCL 4 mg nasal spray. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,305,475 units of Naloxone Hydrochloride Nasal Spray. The delivery order is valued at $1,922.19 and will be completed by January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency to provide various pharmaceutical and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4557384457 NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $3,420.00. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for Narcan (naloxone hydrochloride) 4 milligram nasal spray, with a total potential value of $5,526.00 and a completion date of January 22, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide various pharmaceutical and medical supplies to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,625.76 contract is for the delivery of 4,557,523,715 units of NARCAN 4 MG NASAL SPRAY 2S to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a $6,790.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to treat opioid overdose. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,032.20 contract is for the supply of 4,559,264,470 units of the opioid overdose reversal medication NARCAN 4 mg nasal spray. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract award, valued at $12,222.00, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FD4NZDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,840.00 contract is for the delivery of 4,557,523,711 units of Naloxone Hydrochloride 4 mg Nasal Spray. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 6/6/22 |